PROTARA THERAPEUTIC INC (TARA) Stock Balance Sheet
NASDAQ:TARA - Nasdaq - US74365U1079 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 91.46M | 162.80M | 39.59M | 24.10M | 35.70M | |||
| Marketable Securities | 32.90M | 7.49M | 25.99M | 60.20M | 55.50M | |||
| Receivables | 370.00K | 0.00 | 240.00K | 500.00K | N/A | |||
| Other Current Assets | 1.81M | 1.86M | 2.89M | 1.30M | 1.90M | |||
| Total Current Assets | 127.00M | 172.00M | 69.00M | 86.10M | 93.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.98M | 5.28M | 6.56M | 7.90M | 8.90M | |||
| Investments And Advances | 33.00M | N/A | N/A | 17.90M | 39.50M | |||
| Goodwill | N/A | N/A | N/A | 0.00 | 29.50M | |||
| Other Non-Current Assets | 3.15M | 3.27M | 2.94M | 1.40M | 1.60M | |||
| Total Non-Current Assets | 42.00M | 9.00M | 10.00M | 27.20M | 79.50M | |||
| TOTAL ASSETS | 169.00M | 181.00M | 79.00M | 113.30M | 172.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.71M | 6.53M | 3.72M | 4.20M | 3.30M | |||
| Accounts Payable | 2.31M | 4.43M | 2.43M | 1.60M | 1.00M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 7.02M | 11.00M | 6.15M | 5.70M | 4.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 3.06M | 3.36M | 4.48M | 5.50M | 6.40M | |||
| Total Non-Current Liabilities | 2.98M | 3.00M | 4.85M | 5.50M | 6.40M | |||
| TOTAL LIABILITIES | 10.00M | 14.00M | 11.00M | 11.20M | 10.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -257.00M | -245.00M | -200.00M | -160.00M | -94.00M | |||
| Additional Paid In Capital | 415.00M | 412.00M | 269.00M | 262.70M | 256.10M | |||
| Common Shares | 40.00K | 40.00K | 10.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 90.00K | 0.00 | -30.00K | -700.00K | -200.00K | |||
| Shares Outstanding | 39.00M | 35.00M | 11.00M | 11.30M | 11.20M | |||
| Tangible Book Value per Share | 4.11 | 4.77 | 6.01 | 9.04 | 11.82 | |||
| Total Shareholders' Equity | 158.00M | 167.00M | 68.00M | 102.10M | 161.90M | |||
| TOTAL LIABILITIES AND EQUITY | 169.00M | 181.00M | 79.00M | 113.30M | 172.60M | |||
| Statistics | ||||||||
| Current Ratio | 18.09 | 15.64 | 11.22 | 15.11 | 21.65 | |||
| Return On Assets (ROA) | -26.93% | -24.86% | -50.63% | -58.21% | -27.38% | |||
| Return On Equity (ROE) | -28.80% | -26.95% | -58.82% | -64.59% | -29.18% | |||
All data in USD , ROIC based on taxRate of 0.21